25th Mar 2009 16:30
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
We hereby inform you that on 24 March 2009, the interest of the following Directors in AstraZeneca PLC Ordinary Shares of $0.25 each changed as detailed below. The change in interest relates to the vesting of previously announced awards made in March 2006 under the AstraZeneca Performance Share Plan whereby, following the application of performance measures specified at the time of grant, the individuals concerned have now become beneficially entitled to 89% of the shares originally awarded. In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed. In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting.
|
Name of Director |
Number of Shares Awarded |
Number of Shares Lapsed |
Number of Shares Vested |
Number of Shares Withheld |
Net Number of Shares |
Current Holding |
Percentage of Issued Share Capital |
|
David R Brennan |
73,109 |
8,042 |
65,067 |
26,678 |
38,389 |
See below |
See below |
|
John Patterson |
32,319 |
3,555 |
28,764 |
11,794 |
16,970 |
144,353 |
0.01% |
Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC. One ADS equals one Ordinary Share.
As a result of this transaction, Mr Brennan's interest is now 376,641 Ordinary Shares and 76,188 AstraZeneca ADSs, which together represent approximately 0.031% of the Company's issued ordinary capital.
The market price of AstraZeneca PLC Ordinary Shares of $0.25 each on 24 March 2009 was 2287 pence.
A C N Kemp
Company Secretary
25 March 2009
Related Shares:
Astrazeneca